[Biological effects of leakadin].
作者信息
Garin A M, Lichinitser M R, Dmitrieva N V, Rubtsov B I, Leneva N V
出版信息
Vopr Onkol. 1988;34(2):192-6.
PMID:2964757
Abstract
57 patients with disseminated tumors of various sites received 10 daily doses of 600 mg/m2 leakadin intravenously. The immunostimulating effect was observed (OKT4/OKT8 normalization). The data on leakadin pharmacokinetics are discussed.
摘要
相似文献
1
[Biological effects of leakadin].
Vopr Onkol. 1988;34(2):192-6.
2
[Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine].[卡波西肉瘤患者在使用利卡汀制剂治疗期间免疫指标的动态变化]
Vestn Dermatol Venerol. 1989(9):6-10.
3
A phase I study of intravenous azimexon therapy in human cancer.一项关于静脉注射阿齐美克治疗人类癌症的I期研究。
J Biol Response Mod. 1986 Aug;5(4):313-8.
4
The antineoplastic activity of hexaziridinocyclotriphosphazene (Myko 63) in murine tumors.六氮杂环三磷腈（Myko 63）对小鼠肿瘤的抗肿瘤活性。
Anticancer Res. 1983 Nov-Dec;3(6):425-9.
5
Therapeutic effects of BM 12,531 (Prop. INN azimexon).BM 12,531（国际非专利药品名称：阿齐美克松）的治疗效果。
Recent Results Cancer Res. 1980;75:147-52. doi: 10.1007/978-3-642-81491-4_23.
6
Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.氮丙啶基苯醌（AZQ）用于晚期乳腺癌：癌症与白血病B组II期试验
Cancer Treat Rep. 1982 Oct;66(10):1875-6.
7
[Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].[二碘苯替芬制剂在恶性肿瘤中的临床研究结果]
Klin Med (Mosk). 1975 May;52(5):50-3.
8
Phase II trial of diaziquone in advanced upper aerodigestive cancer.地吖醌用于晚期上消化道癌症的II期试验。
Cancer Treat Rep. 1985 Jan;69(1):141.
9
[Immunotherapy with leakadin in the combined therapy of acoustic neurinomas].[在听神经瘤联合治疗中使用利卡汀进行免疫治疗]
Vestn Otorinolaringol. 1994 Mar-Apr(2):17-9.
10
Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Cancer Treat Rep. 1982 Jun;66(6):1321-5.
Zotero 插件